ANIX
Anixa Biosciences, Inc.
stock NASDAQ

itus develops and acquires patented technologies for the purposes of patent monetization and patent assertion. the company currently has 8 patent portfolios in the areas of key based web conferencing encryption, encrypted cellular communications, nano field emission display ("nfed"), micro electro mechanical systems display ("mems"), j-channel window frame construction, vpn multicast communications, internet telephonic gateway, and enhanced auction technologies. itus's management team has over 30 years of combined experience in patent monetization and patent assertion, and has generated in excess of $150 million patent licensing revenues